Cargando…

An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA

BACKGROUND: Validation of microarrays data by quantitative real-time PCR (qPCR) is often limited by the low amount of available RNA. This raised the possibility to perform validation experiments on the amplified amino allyl labeled RNA (AA-aRNA) leftover from microarrays. To test this possibility, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeanty, Céline, Longrois, Dan, Mertes, Paul-Michel, Wagner, Daniel R, Devaux, Yvan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091691/
https://www.ncbi.nlm.nih.gov/pubmed/20929564
http://dx.doi.org/10.1186/1471-2164-11-542
_version_ 1782203305215131648
author Jeanty, Céline
Longrois, Dan
Mertes, Paul-Michel
Wagner, Daniel R
Devaux, Yvan
author_facet Jeanty, Céline
Longrois, Dan
Mertes, Paul-Michel
Wagner, Daniel R
Devaux, Yvan
author_sort Jeanty, Céline
collection PubMed
description BACKGROUND: Validation of microarrays data by quantitative real-time PCR (qPCR) is often limited by the low amount of available RNA. This raised the possibility to perform validation experiments on the amplified amino allyl labeled RNA (AA-aRNA) leftover from microarrays. To test this possibility, we used an ongoing study of our laboratory aiming at identifying new biomarkers of graft rejection by the transcriptomic analysis of blood cells from brain-dead organ donors. RESULTS: qPCR for ACTB performed on AA-aRNA from 15 donors provided Cq values 8 cycles higher than when original RNA was used (P < 0.001), suggesting a strong inhibition of qPCR performed on AA-aRNA. When expression levels of 5 other genes were measured in AA-aRNA generated from a universal reference RNA, qPCR sensitivity and efficiency were decreased. This prevented the quantification of one low-abundant gene, which was readily quantified in un-amplified and un-labeled RNA. To overcome this limitation, we modified the reverse transcription (RT) protocol that generates cDNA from AA-aRNA as follows: addition of a denaturation step and 2-min incubation at room temperature to improve random primers annealing, a transcription initiation step to improve RT, and a final treatment with RNase H to degrade remaining RNA. Tested on universal reference AA-aRNA, these modifications provided a gain of 3.4 Cq (average from 5 genes, P < 0.001) and an increase of qPCR efficiency (from -1.96 to -2.88; P = 0.02). They also allowed for the detection of a low-abundant gene that was previously undetectable. Tested on AA-aRNA from 15 brain-dead organ donors, RT optimization provided a gain of 2.7 cycles (average from 7 genes, P = 0.004). Finally, qPCR results significantly correlated with microarrays. CONCLUSION: We present here an optimized RT protocol for validation of microarrays by qPCR from AA-aRNA. This is particularly valuable in experiments where limited amount of RNA is available.
format Text
id pubmed-3091691
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30916912011-05-11 An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA Jeanty, Céline Longrois, Dan Mertes, Paul-Michel Wagner, Daniel R Devaux, Yvan BMC Genomics Methodology Article BACKGROUND: Validation of microarrays data by quantitative real-time PCR (qPCR) is often limited by the low amount of available RNA. This raised the possibility to perform validation experiments on the amplified amino allyl labeled RNA (AA-aRNA) leftover from microarrays. To test this possibility, we used an ongoing study of our laboratory aiming at identifying new biomarkers of graft rejection by the transcriptomic analysis of blood cells from brain-dead organ donors. RESULTS: qPCR for ACTB performed on AA-aRNA from 15 donors provided Cq values 8 cycles higher than when original RNA was used (P < 0.001), suggesting a strong inhibition of qPCR performed on AA-aRNA. When expression levels of 5 other genes were measured in AA-aRNA generated from a universal reference RNA, qPCR sensitivity and efficiency were decreased. This prevented the quantification of one low-abundant gene, which was readily quantified in un-amplified and un-labeled RNA. To overcome this limitation, we modified the reverse transcription (RT) protocol that generates cDNA from AA-aRNA as follows: addition of a denaturation step and 2-min incubation at room temperature to improve random primers annealing, a transcription initiation step to improve RT, and a final treatment with RNase H to degrade remaining RNA. Tested on universal reference AA-aRNA, these modifications provided a gain of 3.4 Cq (average from 5 genes, P < 0.001) and an increase of qPCR efficiency (from -1.96 to -2.88; P = 0.02). They also allowed for the detection of a low-abundant gene that was previously undetectable. Tested on AA-aRNA from 15 brain-dead organ donors, RT optimization provided a gain of 2.7 cycles (average from 7 genes, P = 0.004). Finally, qPCR results significantly correlated with microarrays. CONCLUSION: We present here an optimized RT protocol for validation of microarrays by qPCR from AA-aRNA. This is particularly valuable in experiments where limited amount of RNA is available. BioMed Central 2010-10-07 /pmc/articles/PMC3091691/ /pubmed/20929564 http://dx.doi.org/10.1186/1471-2164-11-542 Text en Copyright ©2010 Jeanty et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Jeanty, Céline
Longrois, Dan
Mertes, Paul-Michel
Wagner, Daniel R
Devaux, Yvan
An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA
title An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA
title_full An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA
title_fullStr An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA
title_full_unstemmed An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA
title_short An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA
title_sort optimized protocol for microarray validation by quantitative pcr using amplified amino allyl labeled rna
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091691/
https://www.ncbi.nlm.nih.gov/pubmed/20929564
http://dx.doi.org/10.1186/1471-2164-11-542
work_keys_str_mv AT jeantyceline anoptimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT longroisdan anoptimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT mertespaulmichel anoptimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT wagnerdanielr anoptimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT devauxyvan anoptimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT jeantyceline optimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT longroisdan optimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT mertespaulmichel optimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT wagnerdanielr optimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna
AT devauxyvan optimizedprotocolformicroarrayvalidationbyquantitativepcrusingamplifiedaminoallyllabeledrna